Chemotherapy in "oat cell" carcinoma of the lung

PRELIMINARY RESULTS OF TREATMENT WITH A POLYCHEMOTHERAPY SCHEME OF CYTOKINETIC BASES

Authors

  • José A. Carámbula
  • Alvear Fernández
  • Juan Varela
  • Lem Martínez

Keywords:

aa

Abstract

A preliminary evaluation of the therapeutical results and the tolerance achieved in eight patients with "oat cell" carcinoma of the lung treated with a intennitent scheme of chemoimm \lnotherapy consisting of five drugs -CFM, MTX, ADR, CCNU and Parvum: "EMACC"-, is reported. Under this treatment it was obtained a tumoral remission rate of 5/8 (62.5 %) ; in seven patients it was found an improvement in the perfo-anance status (87.5%), and after seven months of follow-up, 61.5% of the patients are alive, with an acceptable clinical tolerance but a high toxic haematologic cost.
Different considerations about the biological behaviour of the disease and the rational way to focus its treatment are made, the cytocinetic basis on the design of the reported scheme are established and it is remarked the non merggence of encephalic metastases through the treatment time. This last fact is related to the chemoprophylactic effect of CCNU on the C.N.S.

Downloads

Download data is not yet available.

Downloads

Published

1982-03-29

How to Cite

1.
Carámbula JA, Fernández A, Varela J, Martínez L. Chemotherapy in "oat cell" carcinoma of the lung: PRELIMINARY RESULTS OF TREATMENT WITH A POLYCHEMOTHERAPY SCHEME OF CYTOKINETIC BASES. Cir. Urug. [Internet]. 1982 Mar. 29 [cited 2026 Mar. 29];52(2):167-70. Available from: https://replica-revista.scu.org.uy/index.php/cir_urug/article/view/3332

Issue

Vol. 52 No. 2 (1982): Cirugía del Uruguay

Section

Original Article

License

All articles, videos and images published in Revista Cirugía del Uruguay are under the Creative Commons CC licenses, which is a complement to the traditional copyright, in the following terms: first, the authorship of the referred document must always be acknowledged and secondly none of the article or work published in the journal may have commercial purposes of any nature. The authors retain their copyrights and give the magazine the right of first publication of their work, which will be simultaneously  subject to the Creative Commons Attribution-NonCommercial 4.0 International License license that allows the work to be shared whenever  the initial publication is indicated in this journal.

 

Most read articles by the same author(s)